4Filed Sep 2, 8:00 PM ET

Teladoc (TDOC) President Carlos Nueno Sells 6,200 Shares

$TDOC · Teladoc Health, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Teladoc (TDOC) President Carlos Nueno Sells 6,200 Shares

What Happened Carlos Nueno, Teladoc's President, International, had restricted stock units convert into common shares and then sold a portion to cover tax withholding. On 2026-09-01 Nueno converted two awards totaling 13,273 shares (4,556 + 8,717) into TDOC common stock (reported as derivative exercises/conversions). On 2026-09-02 he sold 6,200 shares in an open-market transaction at $6.30 per share, generating proceeds of $39,066. The conversion entries were reported at $0 (typical for RSU vest/settlement), not an out-of-pocket option exercise.

Key Details

  • Transaction dates: conversions on 2026-09-01; open-market sale on 2026-09-02 (filed 2026-09-03). Filing appears timely.
  • Sale: 6,200 shares at $6.30 = $39,066.
  • Conversions: 4,556 and 8,717 shares converted from derivative awards on 2026-09-01 (total 13,273).
  • Footnotes: F1 = RSUs convert one-for-one to common stock; F2 = the 6,200-share sale was to cover tax withholding on RSU vesting. F3/F4 describe the original RSU grant schedules (Mar 19, 2024 and Mar 1, 2025 grants and vesting terms).
  • Shares owned after the transaction: not specified in this Form 4 filing.

Context

  • These filings reflect RSU vesting and a routine tax-withholding sale rather than a cash purchase or directional investment. The derivative-code entries (M) indicate conversion/settlement of restricted stock units, not an options purchase. Sales to cover taxes are common and do not necessarily signal the insider's view of the stock.